IMPACT OF MEDICATION PROFILE REVIEW ON PRESCRIBING IN A GENERAL MEDICINE CLINIC

被引:43
作者
BRITTON, ML [1 ]
LURVEY, PL [1 ]
机构
[1] UNIV OKLAHOMA,HLTH SCI CTR,COLL PHARM,OKLAHOMA CITY,OK 73190
来源
AMERICAN JOURNAL OF HOSPITAL PHARMACY | 1991年 / 48卷 / 02期
关键词
CLINICAL PHARMACISTS; COSTS; DRUG USE; PATIENT INFORMATION; PHARMACY; INSTITUTIONAL; PHYSICIANS; PRESCRIBING; PRESCRIPTIONS; RATIONAL THERAPY;
D O I
10.1093/ajhp/48.2.265
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effect of medication profile review by a clinical pharmacist on prescribing in a general medicine clinic was studied. Patients who were receiving five or more prescription or non-prescription medications were randomly assigned to an intervention group (n = 315) or a control group (n = 257). A clinical pharmacist reviewed the medication profile of each intervention group patient on the day before the patient's clinic visit and attached a written profile review to the medical record for study by the physician during the visit. After each clinic day, the pharmacist obtained updated records of patients in both groups and collected data on the number and cost of medications ordered before and after the visits. After the clinic visits, the average number of medications and the average monthly medication cost per patient decreased by 0.21 and $0.60, respectively, for the intervention group, compared with increases of 0.48 and $3.31 for the control group. The net result of a single profile review was a decrease of 0.69 prescription per patient, for a monthly medication cost savings of $3.91. The number and cost of medications that were discontinued were significantly higher in the intervention group. The intervention group also had significantly fewer drugs added for previously documented medical problems. Medication profile review by a clinical pharmacist reduced both the number and cost of drugs for patients receiving five or more medications.
引用
收藏
页码:265 / 270
页数:6
相关论文
共 15 条
[1]   SUSTAINED IMPROVEMENT IN DRUG DOCUMENTATION, COMPLIANCE, AND DISEASE-CONTROL - A 4-YEAR ANALYSIS OF AN AMBULATORY CARE MODEL [J].
BOND, CA ;
MONSON, R .
ARCHIVES OF INTERNAL MEDICINE, 1984, 144 (06) :1159-1162
[2]   EVALUATION OF FAMILY PHYSICIAN PRESCRIBING - INFLUENCE OF THE CLINICAL PHARMACIST [J].
CARTER, BL ;
HELLING, DK ;
JONES, ME ;
MOESSNER, H ;
WATERBURY, CA .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1984, 18 (10) :817-821
[3]   COST-JUSTIFICATION OF A CLINICAL PHARMACIST-MANAGED ANTICOAGULATION CLINIC [J].
GRAY, DR ;
GARABEDIANRUFFALO, SM ;
CHRETIEN, SD .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1985, 19 (7-8) :575-580
[4]   AN 11-YEAR REVIEW OF THE PHARMACY LITERATURE - DOCUMENTATION OF THE VALUE AND ACCEPTANCE OF CLINICAL PHARMACY [J].
HATOUM, HT ;
CATIZONE, C ;
HUTCHINSON, RA ;
PUROHIT, A .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1986, 20 (01) :33-48
[5]   REVIEW OF LITERATURE ON FACTORS AFFECTING DRUG PRESCRIBING [J].
HEMMINKI, E .
SOCIAL SCIENCE & MEDICINE, 1975, 9 (02) :111-116
[6]   INDICATORS FOR THE SELECTION OF AMBULATORY PATIENTS WHO WARRANT PHARMACIST MONITORING [J].
KOECHELER, JA ;
ABRAMOWITZ, PW ;
SWIM, SE ;
DANIELS, CE .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1989, 46 (04) :729-732
[7]   POLYPHARMACY - CAUSES, CONSEQUENCES, AND CURE [J].
KROENKE, K .
AMERICAN JOURNAL OF MEDICINE, 1985, 79 (02) :149-152
[8]  
LOBECK F, 1989, HOSP COMMUNITY PSYCH, V40, P643
[9]   MEDICATION USE IN AN IMPERFECT WORLD - DRUG MISADVENTURING AS AN ISSUE OF PUBLIC-POLICY .1. [J].
MANASSE, HR .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1989, 46 (05) :929-944
[10]   MEDICATION USE IN AN IMPERFECT WORLD - DRUG MISADVENTURING AS AN ISSUE OF PUBLIC-POLICY .2. [J].
MANASSE, HR .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1989, 46 (06) :1141-1152